Metabolic-cognitive syndrome: Metabolic approach for the management of Alzheimer's disease risk

Journal of Alzheimer's Disease

Volumn 30, Issue SUPPL.2, 2012, Pages

  Frisardi, Vincenza ^a,b   Imbimbo, Bruno P ^c  

^a UNIVERSITY OF BARI   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; NEUROPATHOLOGY; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

EID: 84862983031     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120811     Document Type: Review

References (29)

1. Wimo A, Prince M (2010) World Alzheimer Report. Alzheimer's Disease International, London, pp. 1-12.
2. Comas-Herrera A, Wittenberg R, Pickard L, Knapp M (2007) Cognitive impairment in older people: Future demand for long-term care services and the associated costs. Int J Geriatr Psychiatry 22, 1037-1045. (Pubitemid 47616781)
3. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimer's Disease International (2005) Global prevalence of dementia: A Delphi consensus study. Lancet 366, 2112-2117. (Pubitemid 41797645)
4. Jorm AF, Jolley D (1998) The incidence of dementia: A meta-analysis. Neurology 51, 728-733. (Pubitemid 28449250)
5. Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH (2010) Dementia incidence continues to increase with age in the oldest old: The 90 study. Ann Neurol 67, 114-121.
6. Sousa RM, Ferri CP, Acosta D, Albanese E, Guerra M, Huang Y, Jacob KS, Jotheeswaran AT, Rodriguez JJ, Pichardo GR, Rodriguez MC, Salas A, Sosa AL, Williams J, Zuniga T, Prince M (2009) Contribution of chronic diseases todisability in elderly people in countries with low and middle incomes: A 10/66 Dementia Research Group population based survey. Lancet 374, 1821-1830.
7. Eaker ED, Vierkant RA, Mickel SF (2002) Predictors of nursing home admission and/or death in incident Alzheimer's disease and other dementia cases compared to controls: A population-based study. J Clin Epidemiol 55, 462-468. (Pubitemid 34462242)
8. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P (2009) Epidemiological pathology of dementia: Attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med 6, e1000180.
9. Duara R, Barker WW, Lopez-Alberola R, Loewenstein DA, Grau LB, Gilchrist D, Sevush S, St George-Hyslop S (1996) Alzheimer's disease: Interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 46, 1575-1579. (Pubitemid 26185774)
10. Farrer LA, O'Sullivan DM, Cupples AC, Growdon JH, Myers RH (1989) Assessmentofgenetic risk for Alzheimer's disease among first-degree relatives. Ann Neurol 25, 485-493. (Pubitemid 19136680)
11. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R (1994) Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271, 1004-1010. (Pubitemid 24099921)
12. Mortimer JA, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Rocca WA, Shalat SL, Soininen H, Hofman A, for the Eurodem Risk Factors Research Group (1991) Head trauma as a risk factor for Alzheimer's disease: A collaborative re-analysis of case control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20, S28-S35.
13. Kuller LH, Lopez OL, Newman A, Beauchamp NJ, Burke G, Dulberg C, Fitzpatrick A, Fried L, Haan MN (2003) Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 22, 13-22. (Pubitemid 36131969)
14. Panza F, Solfrizzi V, Logroscino G, Maggi S, Santamato A, Seripa D, Pilotto A (2012) Current epidemiologi-cal approaches to the metabolic-cognitive syndrome. J Alzheimers Dis 30, 31-75.
15. Farooqui AA, Farooqui T, Panza F, Frisardi V (2012) Metabolic syndrome as a risk factor for neurological disorders. Cell Mol Life Sci 69, 741-762.
16. Elias MF, Goodell AL, Waldstein SR (2011) Obesity, cognitive functioning and dementia: Back to the future. J Alzheimers Dis 30, 113-125.
17. Gustafson D (2012) Adiposity and cognitive decline: Underlying mechanisms. J Alzheimers Dis 30, 97-112.
18. de la Monte SM (2012) Triangulated mal-signaling in Alzheimer's disease: Roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed. J Alzheimers Dis 30, 231-249.
19. Wiedmer P, Chaudhary N, Rath M, Yi CX, Ananthakrishnan G, Nogueiras R, Wirth EK, Kirchner H, Schweizer U, Jonas W, Veyrat-Durebex C, Rohner-Jeanrenaud F, Schürmann A, Joost HG, Tschöp MH, Perez-Tilve D (2012) The HPA axis modulates the CNS melanocortin control of liver triacylglyceride metabolism. Physiol Behav 105, 791-799.
20. Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, Pilotto A, Panza F (2010) Isinsulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis 21, 57-63.
21. Lahiri DK, Maloney B (2012) The "LEARn" (latent early-life associated regulation) model: An epigenetic pathway linking metabolic and cognitive disorders. J Alzheimers Dis 30, 15-30.
22. Reitz C (2011) Dyslipidemia and dementia: Current epidemiology, genetic evidence, and mechanisms behind the associations. J Alzheimers Dis, doi: 10.3233/JAD-2011-110599.
23. Guerreiro RJ, Hardy J (2011) Alzheimer's disease genetics: Lessons to improve disease modelling. Biochem Soc Trans 39, 910-916.
24. Frisardi V, Solfrizzi V, Imbimbo PB, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Seripa D, Pilotto A, Capurso A, Panza F (2010) Towards disease-modifying treatment of Alzheimer's disease: Drugs targeting beta-amyloid. Curr Alzheimer Res 7, 40-55.
25. Morris JC (2005) Early-stage and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord 19, 163-165. (Pubitemid 41545853)
26. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746. (Pubitemid 47058377)
27. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Schel-tens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
28. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
29. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.